Cancer IO project

Cancer IO is a new cancer immunotherapy focused top-level collaborative research and innovation project that starts as a part of the Business Finland’s Personalized Health Program. This University of Helsinki coordinated project integrates immuno-oncology (IO) activities at the Universities of Helsinki and Turku, University hospitals and one central hospital, 8 Finnish small or medium enterprises, several cancer patient organizations and the 9 largest IO-investing pharmaceutical companies. With a total funding of 10 million euros, Cancer IO will be one of the largest IO focused research and innovation programs in Europe.

More information about our program is coming up soon!